| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
159 |
| issn |
0300-0664
1365-2265 |
| issueIdentifier |
1 |
| pageRange |
159-159 |
| publicationName |
Clinical Endocrinology |
| startingPage |
159 |
| bibliographicCitation |
Serri O. Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy1. Clinical Endocrinology. 2007 Apr 27;67(1):159. doi: 10.1111/j.1365-2265.2007.02839.x. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7625fa03d751a841741619562caad98c |
| date |
2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/17465996
https://doi.org/10.1111/j.1365-2265.2007.02839.x |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2995
https://portal.issn.org/resource/ISSN/0300-0664
https://portal.issn.org/resource/ISSN/1365-2265 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy1 |
| discusses |
http://id.nlm.nih.gov/mesh/M0003122 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D006966Q000150
http://id.nlm.nih.gov/mesh/D002318Q000209
http://id.nlm.nih.gov/mesh/D009765Q000150 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D007333
http://id.nlm.nih.gov/mesh/D002097Q000032 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54746
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8095 |